Inhibikase Therapeutics Faces Rising BIOSECURE, China Supply Chain and Trial Risks That Could Disrupt GrowthTip Ranks·1 day ago, 01:01 AMIKT-0.62%
Inhibikase rugi bersih Q2 FY26 melebar jadi USD 19,6 juta; belanja R&D melonjak 153,9% jadi USD 13,4 jutaPUBT·2 days ago, 03:12 PMIKT-0.62%
Inhibikase swaps 18,030,000 shares for RA Capital pre-funded warrant in unregistered offeringPUBT·Jul 29 at 03:18 PMIKT-0.62%
Biotech Stocks At 52-Week Highs- IKT, HALO, JAZZ, CORT, LQDArttnews·Jul 27 at 05:33 AMHALO-2.25%IKT-0.62%
RA Capital Management files initial beneficial ownership statement in Inhibikase TherapeuticsPUBT·Jul 17 at 04:55 PMIKT-0.62%
Biotech Stocks Hit 52-Week Highs - TOI, IKT, ANRO, ELV, PRVArttnews·Jul 15 at 02:55 AMANRO-4.49%IKT-0.62%
Inhibikase Therapeutics sells 25,000,000 shares via ATM for gross proceeds of $50 millionPUBT·Jul 14 at 07:01 AMIKT-0.62%
